Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-17

Clinical Trial Update: Efficacy of Pentoxifylline on Cerebrovascular Function in Patients With Cerebral Small Vessel Disease(PERFORM) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating pentoxifylline for cerebrovascular function in cerebral small vessel disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Cerebral Small Vessel Diseases | Phase 4 | Status: UNKNOWN